Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Advancing cancer therapeutics for brain metastases

Bently Doonan, MD, University of Florida, Gainesville, FL, talks on the advances in the field of HER2 breast cancer brain metastases and the survival benefit due to the developments in brain penetrating treatments. As duration of response increases with advances in cancer therapeutics, the number of patients developing brain metastases will also increase. Dr Doonan therefore emphasizes the significance of advancing therapeutics for the treatment of brain metastases. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.